Omar Ishrak, Medtronic PLC
Total compensation: $13,899,744 for the year ended April 30, 2019
Nonequity incentive pay: $6,748,488
Other compensation: $101,114
Exercised stock options: $0
Value realized on vesting shares: $5,359,311
New stock options: 305,018
CEO pay ratio: 240-1
Median employee pay: $74,206
Total fiscal 2019 shareholder return: 13.3%
Note: Ishrak's overall compensation was down 27% from the previous fiscal year, mainly from his decision not to exercise any of his previously issued stock options. The year before, he had exercised $4.3 million worth. It was also Ishrak's lowest total in the previous five years.
Ishrak and other executive officers at Medtronic received 3% increases to their base salaries, but they generally earned less from their cash-based incentive goals, which include both an annual incentive and long-term performance plan targets.
Medtronic, which finished its fiscal year in strong fashion, exceeded its revenue and cash-flow targets for the annual performance-based cash awards but fell shy of its earnings-per-share target with non-GAAP diluted EPS of $5.17, 8 cents-per-share below target. The combined performance was enough to exceed the target for the year and earned Ishrak $3.2 million of his cash-incentive pay.
Medtronic's long-term performance-plan goals cover performance over three years and its revenue growth and return on invested capital came in below target for the three periods covering fiscal 2017-2019. That performance only earned executives 79% of the targeted payout percentage. Ishrak earned $3.6 million of his $4.5 million target for the three-year period.